VAERS Explorer
Back to explore

Report #2896179

Received May 11, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
May 4, 2026
Onset
May 4, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (1)

Myalgia

Symptom narrative

Muscle ache; This non-serious case was reported by a consumer and described the occurrence of muscle pain in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 04-MAY-2026, the patient received Shingrix .5 ml. On 04-MAY-2026, less than a day after receiving Shingrix, the patient experienced muscle pain (Verbatim: Muscle ache). The outcome of the muscle pain was not resolved. It was unknown if the reporter considered the muscle pain to be related to Shingrix. It was unknown if the company considered the muscle pain to be related to Shingrix. Additional Information: GSK Receipt Date: 04-MAY-2026 The batch number was not provided upon follow- up with the reporter.